BACKGROUND
RT001 is a deuterated ethyl linoleate that inhibits lipid peroxidation and is hypothesized to reduce cellular damage and recover mitochondrial function in degenerative diseases such as Friedreich's ataxia.
OBJECTIVE
To evaluate the safety, pharmacokinetics, and preliminary efficacy of